Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Heart Transplant Market by Type (Ventricular Assist Devices, Total Artificial Hearts, Others) and by End User (Hospitals, Cardiac Institutes, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

A11663

Pages: NA

Charts: NA

Tables: NA

A heart transplant is a surgery done to treat most serious cases of heart diseases. It is a treatment option for patients who are on the verge of heart failure and is often needed when lifestyle changes, medications, and less invasive procedures have not succeeded. Heart transplant surgery usually lasts for four hours during which a patient is placed on a heart-lung machine that keeps blood circulating in the body. Surgeon removes patient's heart, leaving back wall of the left atrium and pulmonary vein opening intact. This helps prepare patient to receive donor's heart. Once the donor's heart is stitched into place the heart begins beating in the patient's body.

Impact of COVID-19 on the Medical Device Market

COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

There has been an increase in the demand for medical supplies to take care of the infected population. Respiratory support devices such as atomizers, life support machines, oxygen generators, and monitors are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment, including masks, gloves, and protective eyeglasses. An increase has been witnessed in the need for medical supplies, both from healthcare professionals and the civil population for precautionary measures, owing to the rise in the number of COVID-19 cases worldwide. Manufacturers of these products have a chance to capitalize on this increased demand for medical supplies to ensure an adequate and continuous supply of personal protective equipment in the market.

With COVID-19 the supply chain of the raw material required to manufacture heart transplant devices has been disrupted in many countries. In addition, the market growth for heart transplant devices is also declining as the manufacturers of these devices have slowed down their production owing  to  the pandemic. Therefore, COVID 19 is expected to have a significant impact on the heart transplant market.

Top Impacting Factors

  • In the last decade, number of cases of coronary artery diseases and heart failures have increased at a significant rate. These cardiovascular diseases often lead to need for a heart transplant. This is hence one of the major factors that positively influence growth of the heart transplant market.
  • Increase in geriatric population and rise in number of patients with high blood cholesterol levels also act as major drivers for the heart transplant market.
  • In addition, the mortality rate of patients succumbing to heart failure is on the rise, which has led to rise in demand for heart transplants globally. Changes in lifestyle and food habits are also factors that have increased chances of developing cardiovascular diseases. These factors drive the heart transplant market growth.
  • However, lack of skilled surgeons to perform successful heart transplant surgeries and lack of heart donors are the major factors that are expected to impede the heart transplant market growth during the forecast period.

Key Market Trends

In May 2019, Pfizer, Inc. received an approval from the Food and Drug Administration (FDA) for Vyndaqel and Vyndamax drugs, which can be used to treat hereditary transthyretin-mediated amyloidosis or cardiomyopathy that can lead to heart failure.

In March 2018, CareDx, Inc. launched Heartcare. It is a comprehensive diagnostic solution that helps in surveillance of heart patients by combining AlloMap and AlloSure-Heart.

North America and South America dominate the global heart transplant market, owing to high healthcare spending, well-developed technology for heart transplants, and increase in support of governments for research and development of better heart transplant technologies.

Europe has the second position in the heart transplant market, owing to rise in government support for funding research and development activities aimed at launching feasible heart transplant devices for surveillance of patients after transplant.

Asia-Pacific is the region with tremendous heart transplant market growth in recent times. The heart transplant cost in countries such as China and India is way less than developed nations, which helps attract a lot of global patients to the region. Furthermore, rise in demand for quality heart transplant devices is also projected to lead to the application of advanced equipment, which is expected to increase growth of the heart transplant market.

Key Benefits of the Report

  • This study presents the analytical depiction of the heart transplant industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the heart transplant market share.
  • The current market is quantitatively analyzed to highlight the heart transplant market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in the coming years

Questions Answered in the Global Heart Transplant Report

  • Which are the leading players active in the aplastic anemia treatment market?
  • How is each segment of the market expected to grow during the forecast period?
  • What are the adoption trends for the aplastic anemia treatment market in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps in the market?
  • What are the impacts of COVID-19 on the industry?
  • What is aplastic anemia?
  • What are the current and predicted trends of the market?

 Key Market Segments

  • By Type
    • Ventricular Assist Devices
    • Total Artificial Hearts
    • Others
  • By End User
    • Hospitals
    • Cardiac Institutes
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of LAMEA

 
Key Market Players

  • Apaxis Medical, Inc.
  • HeartWare International, Inc.
  • CardiacAssist, Inc.
  • Calon Cardio
  • CARMAT SA
  • Thoratec Corporation
  • Optum, Inc.
  • SynCardia Systems, LLC

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: HEART TRANSPLANT MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Ventricular Assist Devices

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Total Artificial Hearts

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Others

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: HEART TRANSPLANT MARKET, BY END USER

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End User

    • 5.2. Hospitals

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Cardiac Institutes

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Others

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: HEART TRANSPLANT MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Type

      • 6.2.3. Market Size and Forecast, By End User

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Heart Transplant Market

        • 6.2.5.1. Market Size and Forecast, By Type
        • 6.2.5.2. Market Size and Forecast, By End User

      • 6.2.6. Canada Heart Transplant Market

        • 6.2.6.1. Market Size and Forecast, By Type
        • 6.2.6.2. Market Size and Forecast, By End User

      • 6.2.7. Mexico Heart Transplant Market

        • 6.2.7.1. Market Size and Forecast, By Type
        • 6.2.7.2. Market Size and Forecast, By End User

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Type

      • 6.3.3. Market Size and Forecast, By End User

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Heart Transplant Market

        • 6.3.5.1. Market Size and Forecast, By Type
        • 6.3.5.2. Market Size and Forecast, By End User

      • 6.3.6. Germany Heart Transplant Market

        • 6.3.6.1. Market Size and Forecast, By Type
        • 6.3.6.2. Market Size and Forecast, By End User

      • 6.3.7. Italy Heart Transplant Market

        • 6.3.7.1. Market Size and Forecast, By Type
        • 6.3.7.2. Market Size and Forecast, By End User

      • 6.3.8. Spain Heart Transplant Market

        • 6.3.8.1. Market Size and Forecast, By Type
        • 6.3.8.2. Market Size and Forecast, By End User

      • 6.3.9. UK Heart Transplant Market

        • 6.3.9.1. Market Size and Forecast, By Type
        • 6.3.9.2. Market Size and Forecast, By End User

      • 6.3.10. Russia Heart Transplant Market

        • 6.3.10.1. Market Size and Forecast, By Type
        • 6.3.10.2. Market Size and Forecast, By End User

      • 6.3.11. Rest Of Europe Heart Transplant Market

        • 6.3.11.1. Market Size and Forecast, By Type
        • 6.3.11.2. Market Size and Forecast, By End User

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Type

      • 6.4.3. Market Size and Forecast, By End User

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Heart Transplant Market

        • 6.4.5.1. Market Size and Forecast, By Type
        • 6.4.5.2. Market Size and Forecast, By End User

      • 6.4.6. Japan Heart Transplant Market

        • 6.4.6.1. Market Size and Forecast, By Type
        • 6.4.6.2. Market Size and Forecast, By End User

      • 6.4.7. India Heart Transplant Market

        • 6.4.7.1. Market Size and Forecast, By Type
        • 6.4.7.2. Market Size and Forecast, By End User

      • 6.4.8. South Korea Heart Transplant Market

        • 6.4.8.1. Market Size and Forecast, By Type
        • 6.4.8.2. Market Size and Forecast, By End User

      • 6.4.9. Australia Heart Transplant Market

        • 6.4.9.1. Market Size and Forecast, By Type
        • 6.4.9.2. Market Size and Forecast, By End User

      • 6.4.10. Thailand Heart Transplant Market

        • 6.4.10.1. Market Size and Forecast, By Type
        • 6.4.10.2. Market Size and Forecast, By End User

      • 6.4.11. Malaysia Heart Transplant Market

        • 6.4.11.1. Market Size and Forecast, By Type
        • 6.4.11.2. Market Size and Forecast, By End User

      • 6.4.12. Indonesia Heart Transplant Market

        • 6.4.12.1. Market Size and Forecast, By Type
        • 6.4.12.2. Market Size and Forecast, By End User

      • 6.4.13. Rest of Asia Pacific Heart Transplant Market

        • 6.4.13.1. Market Size and Forecast, By Type
        • 6.4.13.2. Market Size and Forecast, By End User

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Type

      • 6.5.3. Market Size and Forecast, By End User

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Heart Transplant Market

        • 6.5.5.1. Market Size and Forecast, By Type
        • 6.5.5.2. Market Size and Forecast, By End User

      • 6.5.6. South Africa Heart Transplant Market

        • 6.5.6.1. Market Size and Forecast, By Type
        • 6.5.6.2. Market Size and Forecast, By End User

      • 6.5.7. Saudi Arabia Heart Transplant Market

        • 6.5.7.1. Market Size and Forecast, By Type
        • 6.5.7.2. Market Size and Forecast, By End User

      • 6.5.8. UAE Heart Transplant Market

        • 6.5.8.1. Market Size and Forecast, By Type
        • 6.5.8.2. Market Size and Forecast, By End User

      • 6.5.9. Argentina Heart Transplant Market

        • 6.5.9.1. Market Size and Forecast, By Type
        • 6.5.9.2. Market Size and Forecast, By End User

      • 6.5.10. Rest of LAMEA Heart Transplant Market

        • 6.5.10.1. Market Size and Forecast, By Type
        • 6.5.10.2. Market Size and Forecast, By End User

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. SynCardia Systems, LLC

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. HeartWare International, Inc.

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Apaxis Medical, Inc.

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Calon Cardio

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Optum, Inc.

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Thoratec Corporation

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. CardiacAssist, Inc.

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. CARMAT SA

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL HEART TRANSPLANT MARKET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL HEART TRANSPLANT MARKET FOR VENTRICULAR ASSIST DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL HEART TRANSPLANT MARKET FOR TOTAL ARTIFICIAL HEARTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL HEART TRANSPLANT MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL HEART TRANSPLANT MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL HEART TRANSPLANT MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL HEART TRANSPLANT MARKET FOR CARDIAC INSTITUTES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL HEART TRANSPLANT MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL HEART TRANSPLANT MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. NORTH AMERICA HEART TRANSPLANT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. NORTH AMERICA HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 12. NORTH AMERICA HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 13. U.S. HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 14. U.S. HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 15. CANADA HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 16. CANADA HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 17. MEXICO HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 18. MEXICO HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 19. EUROPE HEART TRANSPLANT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 20. EUROPE HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 21. EUROPE HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 22. FRANCE HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 23. FRANCE HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 24. GERMANY HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 25. GERMANY HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 26. ITALY HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 27. ITALY HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 28. SPAIN HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 29. SPAIN HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 30. UK HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 31. UK HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 32. RUSSIA HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 33. RUSSIA HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 34. REST OF EUROPE HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 35. REST OF EUROPE HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 36. ASIA-PACIFIC HEART TRANSPLANT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 37. ASIA-PACIFIC HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 38. ASIA-PACIFIC HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 39. CHINA HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 40. CHINA HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 41. JAPAN HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 42. JAPAN HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 43. INDIA HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 44. INDIA HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 45. SOUTH KOREA HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 46. SOUTH KOREA HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 47. AUSTRALIA HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 48. AUSTRALIA HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 49. THAILAND HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 50. THAILAND HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 51. MALAYSIA HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 52. MALAYSIA HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 53. INDONESIA HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 54. INDONESIA HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 55. REST OF ASIA PACIFIC HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 56. REST OF ASIA PACIFIC HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 57. LAMEA HEART TRANSPLANT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 58. LAMEA HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 59. LAMEA HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 60. BRAZIL HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 61. BRAZIL HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 62. SOUTH AFRICA HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 63. SOUTH AFRICA HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 64. SAUDI ARABIA HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 65. SAUDI ARABIA HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 66. UAE HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 67. UAE HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 68. ARGENTINA HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 69. ARGENTINA HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 70. REST OF LAMEA HEART TRANSPLANT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 71. REST OF LAMEA HEART TRANSPLANT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 72. SYNCARDIA SYSTEMS, LLC: KEY EXECUTIVES
  • TABLE 73. SYNCARDIA SYSTEMS, LLC: COMPANY SNAPSHOT
  • TABLE 74. SYNCARDIA SYSTEMS, LLC: OPERATING SEGMENTS
  • TABLE 75. SYNCARDIA SYSTEMS, LLC: PRODUCT PORTFOLIO
  • TABLE 76. SYNCARDIA SYSTEMS, LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 77. HEARTWARE INTERNATIONAL, INC.: KEY EXECUTIVES
  • TABLE 78. HEARTWARE INTERNATIONAL, INC.: COMPANY SNAPSHOT
  • TABLE 79. HEARTWARE INTERNATIONAL, INC.: OPERATING SEGMENTS
  • TABLE 80. HEARTWARE INTERNATIONAL, INC.: PRODUCT PORTFOLIO
  • TABLE 81. HEARTWARE INTERNATIONAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 82. APAXIS MEDICAL, INC.: KEY EXECUTIVES
  • TABLE 83. APAXIS MEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 84. APAXIS MEDICAL, INC.: OPERATING SEGMENTS
  • TABLE 85. APAXIS MEDICAL, INC.: PRODUCT PORTFOLIO
  • TABLE 86. APAXIS MEDICAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 87. CALON CARDIO: KEY EXECUTIVES
  • TABLE 88. CALON CARDIO: COMPANY SNAPSHOT
  • TABLE 89. CALON CARDIO: OPERATING SEGMENTS
  • TABLE 90. CALON CARDIO: PRODUCT PORTFOLIO
  • TABLE 91. CALON CARDIO: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 92. OPTUM, INC.: KEY EXECUTIVES
  • TABLE 93. OPTUM, INC.: COMPANY SNAPSHOT
  • TABLE 94. OPTUM, INC.: OPERATING SEGMENTS
  • TABLE 95. OPTUM, INC.: PRODUCT PORTFOLIO
  • TABLE 96. OPTUM, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 97. THORATEC CORPORATION: KEY EXECUTIVES
  • TABLE 98. THORATEC CORPORATION: COMPANY SNAPSHOT
  • TABLE 99. THORATEC CORPORATION: OPERATING SEGMENTS
  • TABLE 100. THORATEC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 101. THORATEC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 102. CARDIACASSIST, INC.: KEY EXECUTIVES
  • TABLE 103. CARDIACASSIST, INC.: COMPANY SNAPSHOT
  • TABLE 104. CARDIACASSIST, INC.: OPERATING SEGMENTS
  • TABLE 105. CARDIACASSIST, INC.: PRODUCT PORTFOLIO
  • TABLE 106. CARDIACASSIST, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 107. CARMAT SA: KEY EXECUTIVES
  • TABLE 108. CARMAT SA: COMPANY SNAPSHOT
  • TABLE 109. CARMAT SA: OPERATING SEGMENTS
  • TABLE 110. CARMAT SA: PRODUCT PORTFOLIO
  • TABLE 111. CARMAT SA: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL HEART TRANSPLANT MARKET SEGMENTATION
  • FIGURE 2. GLOBAL HEART TRANSPLANT MARKET
  • FIGURE 3. SEGMENTATION HEART TRANSPLANT MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN HEART TRANSPLANT MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALHEART TRANSPLANT MARKET
  • FIGURE 11. HEART TRANSPLANT MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. HEART TRANSPLANT MARKET FOR VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. HEART TRANSPLANT MARKET FOR TOTAL ARTIFICIAL HEARTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. HEART TRANSPLANT MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. HEART TRANSPLANT MARKET SEGMENTATION, BY BY END USER
  • FIGURE 16. HEART TRANSPLANT MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. HEART TRANSPLANT MARKET FOR CARDIAC INSTITUTES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. HEART TRANSPLANT MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 20. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 21. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 22. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 23. COMPETITIVE DASHBOARD
  • FIGURE 24. COMPETITIVE HEATMAP: HEART TRANSPLANT MARKET
  • FIGURE 25. TOP PLAYER POSITIONING, 2024
  • FIGURE 26. SYNCARDIA SYSTEMS, LLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 27. SYNCARDIA SYSTEMS, LLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 28. SYNCARDIA SYSTEMS, LLC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 29. HEARTWARE INTERNATIONAL, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 30. HEARTWARE INTERNATIONAL, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 31. HEARTWARE INTERNATIONAL, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 32. APAXIS MEDICAL, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 33. APAXIS MEDICAL, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 34. APAXIS MEDICAL, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 35. CALON CARDIO: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. CALON CARDIO: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. CALON CARDIO: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. OPTUM, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. OPTUM, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. OPTUM, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. THORATEC CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. THORATEC CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. THORATEC CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. CARDIACASSIST, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. CARDIACASSIST, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. CARDIACASSIST, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. CARMAT SA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. CARMAT SA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. CARMAT SA: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Heart Transplant Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved